Crisaborole Ointment 2% Skin Biomarker Biopsy Study in Atopic Dermatitis
Clinical trial NCT03233529 · COMPLETED
Trial details
- NCT number
- NCT03233529
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-31
- Primary completion
- 2018-05-04
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.